Will psilocybin lose its magic in the clinical setting?
Therapeutic Advances in Psychopharmacology January 1, 2022 Caroline Hayes, Mourad Wahba, Stuart Watson 17 citations
Psilocybin-assisted psychotherapy faces unique challenges as it moves from research into clinical practice. Patients often arrive with overly positive expectations shaped by media coverage, and the drug's effects can increase suggestibility, requiring specially trained therapists. The authors recommend measures for phase 3 trials and clinicians to address these issues, aiming to help psilocybin become a licensed medication that suitable patients can access relatively easily. Practicing psychiatrists should be aware of these potential pitfalls, as they will be responsible for future prescribing.